Ten Gardnerella vaginalis short-rod-to-coccobacillary bodies appear in eight groupings: six isolated singles and two touching pairs.
Species representative reconstruction Editorially reviewed

Representative G. vaginalis pleomorphic short rods and coccobacilli, shown as ten bodies in six single and two paired groupings. The current route retains its evolving nomenclatural boundary; this reconstruction does not imply visual separation from other Gardnerella species or diagnosis and is not a micrograph.

WikiBiome / Microbiome MedicineCurrent-species-taxonomy-, type-strain-, primary-description-, and evolving-nomenclatural-boundary-informed representative reconstruction
Scientific media record1 verified identifier
Subject
Gardnerella vaginalistaxon · species
Review
Editorial review completeIdentifiers authority-verified · Accessibility validated · · gardnerella-vaginalis|gardnerella-vaginalis-morphology-v1.webp
Digital source
Trained-algorithmic mediaCreated with a trained generative algorithm and reviewed by WikiBiome for subject identity, scientific framing, identifiers, provenance, and accessibility.
License
CC BY-SA 4.0Created

See also the genus page: Gardnerella

Gardnerella vaginalis is the primary causative agent of bacterial vaginosis (BV), the most common vaginal infection worldwide. This species page focuses on the species-level biology—particularly the vaginolysin cytotoxin and biofilm architecture—that distinguish G. vaginalis from the broader genus.

Evidence map8 cited passagesInspect provenance +
01
Vaginolysin—An Iron-Regulated Toxin

VLY expression is iron-regulated—iron availability modulates vaginolysin production, connecting Gardnerella virulence to the mucosal iron landscape controlled by lactoferrin.

02
Vaginolysin—An Iron-Regulated Toxin

Statin repurposing: Because VLY requires membrane cholesterol for binding, statins (which deplete membrane cholesterol) can reduce vaginolysin cytotoxicity. Simvastatin at sub-antimicrobial doses significantly reduces G. vaginalis biofilm virulence in vitro. This is a Cureva-relevant drug repurposing lead.

03
Disease Associations

BV: The defining organism—clue cells (vaginal epithelial cells coated with G. vaginalis) are a diagnostic criterion.

04
Disease Associations

HPV persistence: G. vaginalis-dominant vaginal microbiomes associated with HPV16 persistence.

05
Disease Associations

Preterm birth: BV and G. vaginalis abundance associated with preterm birth risk.

06
Disease Associations

Male infertility: Detected in semen; associated with impaired sperm quality.

07
Disease Associations

Prostatitis: Part of the prostatitis-associated urogenital microbiome.

08
Disease Associations

PCOS: Part of PCOS-associated vaginal microbiome shifts.

Contents1. Vaginolysin—An Iron-Regulated Toxin2. Biofilm Architecture3. Disease Associations4. Cross-References

Vaginolysin—An Iron-Regulated Toxin#

Vaginolysin (VLY) is a cholesterol-dependent cytolysin (CDC) that is G. vaginalis's primary virulence factor. VLY forms pores in human vaginal epithelial cells by binding to the cholesterol-rich membrane complement regulatory molecule CD59.

VLY expression is iron-regulated—iron availability modulates vaginolysin production, connecting Gardnerella virulence to the mucosal iron landscape controlled by Lactoferrin.[1]Roberts 2019 — Mucosal Lactoferrin Response to Genital Tract Infections Is Associated with Iron and Nutritional BiomarkersS. A. Roberts, L. Brabin, S. Diallo et al. · 2019Open reference 1

Statin repurposing: Because VLY requires membrane cholesterol for binding, statins (which deplete membrane cholesterol) can reduce vaginolysin cytotoxicity. Simvastatin at sub-antimicrobial doses significantly reduces G. vaginalis biofilm virulence in vitro.[2]Abdelmaksoud 2017 — Association between Statin Use, the Vaginal Microbiome, and Gardnerella vaginalis Vaginolysin-Mediated CytotoxicityAbdelmaksoud AA, Girerd PH, Garcia EM et al. · 2017Open reference 2 This is a Cureva-relevant drug repurposing lead.

Biofilm Architecture#

G. vaginalis initiates the polymicrobial biofilm that defines BV:

  1. G. vaginalis adheres to vaginal epithelial cells and forms the initial biofilm scaffold.
  2. Atopobium (A. vaginae) embeds within the Gardnerella biofilm, becoming protected from metronidazole.
  3. Sneathia, Megasphaera, and Prevotella colonize the biofilm surface.

This biofilm architecture explains BV recurrence: metronidazole kills planktonic bacteria but the biofilm persists, enabling rapid recolonization.

Disease Associations#

BV: The defining organism—clue cells (vaginal epithelial cells coated with G. vaginalis) are a diagnostic criterion.[3]Ughade 2024 — Navigating the Microbial Landscape: Understanding Dysbiosis in Human Genital Tracts and Its Impact on FertilityPrachi A. Ughade, Deepti Shrivastava, Kamlesh Chaudhari · 2024Open reference 3

HPV persistence: G. vaginalis-dominant vaginal microbiomes associated with HPV16 persistence.[4]Yang 2020 — Vaginal Microbiome Alterations in HPV16 Infection by Shotgun MetagenomicsQian Yang, Yaping Wang, Xinyi Wei et al. · 2020Open reference 4 Preterm birth: BV and G. vaginalis abundance associated with preterm birth risk.[5]Pruski & Correia 2021 — Direct On-Swab Metabolic Profiling of Vaginal Microbiome Host Interactions During Pregnancy and Preterm BirthPamela Pruski, Gonçalo D. S. Correia, Holly V. Lewis et al. · 2021Open reference 5

Male infertility: Detected in semen; associated with impaired sperm quality.[6]Magill 2023 — Male Infertility and the Human MicrobiomeMagill RG, MacDonald SM · 2023Open reference 6 Prostatitis: Part of the prostatitis-associated urogenital microbiome.[7]Magri 2018 — Multidisciplinary Approach to ProstatitisVittorio Magri, Matteo Boltri, Tommaso Cai et al. · 2018Open reference 7 PCOS: Part of PCOS-associated vaginal microbiome shifts.[8]Zheng 2024 — Differential enrichment of bacteria and phages in vaginal microbiomes in PCOS and obesity: shotgun sequencing analysisZheng S, Chen H, Yang H et al. · 2024Open reference 8

Endometriosis: Depleted in cervical samples (see genus page Gardnerella).

Cross-References#

Generated evidence record

References 10

Numbered by first appearance in the article, then reconciled with its declared source list.

  1. 1

    S. A. Roberts, L. Brabin, S. Diallo et al. (2019). Roberts 2019 — Mucosal Lactoferrin Response to Genital Tract Infections Is Associated with Iron and Nutritional Biomarkers. European Journal of Clinical Nutrition.

  2. 2

    Abdelmaksoud AA, Girerd PH, Garcia EM et al. (2017). Abdelmaksoud 2017 — Association between Statin Use, the Vaginal Microbiome, and Gardnerella vaginalis Vaginolysin-Mediated Cytotoxicity. PLOS ONE.

  3. 3

    Prachi A. Ughade, Deepti Shrivastava, Kamlesh Chaudhari (2024). Ughade 2024 — Navigating the Microbial Landscape: Understanding Dysbiosis in Human Genital Tracts and Its Impact on Fertility. Cureus.

  4. 4

    Qian Yang, Yaping Wang, Xinyi Wei et al. (2020). Yang 2020 — Vaginal Microbiome Alterations in HPV16 Infection by Shotgun Metagenomics. Frontiers in Cellular and Infection Microbiology.

  5. 5

    Pamela Pruski, Gonçalo D. S. Correia, Holly V. Lewis et al. (2021). Pruski & Correia 2021 — Direct On-Swab Metabolic Profiling of Vaginal Microbiome Host Interactions During Pregnancy and Preterm Birth. Nature Communications.

  6. 6

    Magill RG, MacDonald SM (2023). Magill 2023 — Male Infertility and the Human Microbiome. Frontiers in Reproductive Health.

  7. 7

    Vittorio Magri, Matteo Boltri, Tommaso Cai et al. (2018). Magri 2018 — Multidisciplinary Approach to Prostatitis. Archivio Italiano di Urologia e Andrologia.

  8. 8

    Zheng S, Chen H, Yang H et al. (2024). Zheng 2024 — Differential enrichment of bacteria and phages in vaginal microbiomes in PCOS and obesity: shotgun sequencing analysis. Frontiers in Microbiomes.

  9. 9

    John MacSharry, Zsuzsanna Kovacs, Yongjing Xie et al. (2024). MacSharry 2024 — Endometriosis Specific Vaginal Microbiota Links to Urine and Serum N-Glycome. Scientific Reports.

  10. 10

    Georgina Quaranta, Mauro Pittiruti, Brunella Posteraro et al. (2019). Quaranta 2019 — FMT as a Potential Tool for Female Reproductive Tract Diseases (Review). Frontiers in Immunology.

Knowledge graph

Article network

Researcher discussion

Connect the evidence

Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.

0 posts

No discussion yet. Start with a precise question or a source-backed observation.

Transparent record

Activity and accepted changes

Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.

1 events
  1. published revision

    massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers

    WikiBiome Deploy Bot · +74 −0

    Inspect exact Git diff ↗
Continue exploring

Every article is a doorway.

Generated from the WikiBiome Markdown vault and reconciled against its source registry.

10 references · 1 backlinks · 10 indexed topics